Can we correct the cardiovascular risks with treatment?

J. Stradling (Oxford, United Kingdom)

Source: Annual Congress 2005 - Cardiovascular disease and obstructive sleep apnoea: risks and remedy
Session: Cardiovascular disease and obstructive sleep apnoea: risks and remedy
Session type: Symposium
Number: 120
Disease area: Sleep and breathing disorders

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Stradling (Oxford, United Kingdom). Can we correct the cardiovascular risks with treatment?. Annual Congress 2005 - Cardiovascular disease and obstructive sleep apnoea: risks and remedy

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Continuous positive airway pressure (CPAP) supported by telemedicine improves sleepiness and quality of life but not blood pressure in high cardiovascular risk obstructive sleep apnea (OSA): A randomized, controlled trial
Source: Annual Congress 2013 –Ask, see and do: old and new technology in sleep disordered breathing
Year: 2013


Sleep apnoea and systemic hypertension
Source: Eur Respir Mon 2010; 50: 150-173
Year: 2010


Can psychological factors help us to determine adherence to CPAP? A prospective study
Source: Eur Respir J 2004; 24: 461-465
Year: 2004



CPAP treatment reduce blood pressure in patients with recent diagnosis of systemic hypertension and obstructive sleep apnoea -hypopnoea (OSAH). A controlled study
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008


Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment
Source: Eur Respir J 2012; 39: 906-912
Year: 2012



Nasal continuous positive airway pressure in stroke patients with sleep apnoea: a randomized treatment study
Source: Eur Respir J 2001; 18: 630-634
Year: 2001



Resting electrocardiographic (EKG) changes, the cardiovascular risk factors and the effect of CPAP (continuous positive airways pressure) therapy on high blood pressure evolution in patients with sleep apnoea syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 564s
Year: 2005

Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients?
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006


The influence of 3-weeks‘ therapy of continous positive airway pressure (CPAP) on serum leptin and homocysteine concentration in patients with obstructive sleep apnea (OSA)
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005


Improvement of machine compliance when switching patients with OSA to C-flex
Source: Annual Congress 2005 - What should we know about our SAS patients
Year: 2005


Treatment options for central sleep apnea (including auto-CPAP)
Source: Annual Congress 2005 - Central sleep apnoea
Year: 2005

Controlled, prospective trial of psychosocial function before and after continuous positive airway pressure therapy
Source: Eur Respir J 2001; 18: 996-1002
Year: 2001



CPAP: evidence-based data regarding compliance, efficacy and side-effects
Source: Annual Congress 2005 - PG12 - Sleep-related problems: treatment of obstructive sleep apnoea - current concepts and perspectives
Year: 2005


Early treatment of obstructive apnoea and stroke outcome: a randomised controlled trial
Source: Eur Respir J 2011; 37: 1128-1136
Year: 2011



Positive effect of CPAP treatment on the control of difficult-to-treat hypertension
Source: Eur Respir J 2007; 29: 951-957
Year: 2007



Compliance with continuous positive airway pressure in patients with sleep apnea/hypopnea syndrome
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007



Continuous positive airway pressure treatment for sleep apnoea: compliance increases with time in continuing users
Source: Eur Respir J 2006; 27: 761-766
Year: 2006



Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years
Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea
Year: 2006


Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005


Pharmacological management of sleep-disordered breathing
Source: Eur Respir Mon 2010; 50: 321-339
Year: 2010